3TAL
| Crystal structure of NurA with manganese | Descriptor: | DNA double-strand break repair protein nurA, GLYCEROL, MANGANESE (II) ION | Authors: | Chae, J, Kim, Y.C, Cho, Y. | Deposit date: | 2011-08-04 | Release date: | 2011-11-23 | Last modified: | 2013-07-03 | Method: | X-RAY DIFFRACTION (3.15 Å) | Cite: | Crystal structure of the NurA-dAMP-Mn2+ complex Nucleic Acids Res., 40, 2012
|
|
3TAZ
| Crystal structure of NurA bound to dAMP and manganese | Descriptor: | 2'-DEOXYADENOSINE-5'-MONOPHOSPHATE, DNA double-strand break repair protein nurA, GLYCEROL, ... | Authors: | Chae, J, Kim, Y.C, Cho, Y. | Deposit date: | 2011-08-04 | Release date: | 2011-11-23 | Last modified: | 2024-03-20 | Method: | X-RAY DIFFRACTION (3.2 Å) | Cite: | Crystal structure of the NurA-dAMP-Mn2+ complex Nucleic Acids Res., 40, 2012
|
|
3TAI
| Crystal structure of NurA | Descriptor: | DNA double-strand break repair protein nurA, GLYCEROL | Authors: | Chae, J, Kim, Y.C, Cho, Y. | Deposit date: | 2011-08-04 | Release date: | 2011-11-23 | Last modified: | 2013-07-03 | Method: | X-RAY DIFFRACTION (2.82 Å) | Cite: | Crystal structure of the NurA-dAMP-Mn2+ complex Nucleic Acids Res., 40, 2012
|
|
3T1I
| Crystal Structure of Human Mre11: Understanding Tumorigenic Mutations | Descriptor: | 2,3-DIHYDROXY-1,4-DITHIOBUTANE, Double-strand break repair protein MRE11A, GLYCEROL, ... | Authors: | Park, Y.B, Chae, J, Kim, Y, Cho, Y. | Deposit date: | 2011-07-22 | Release date: | 2011-11-30 | Method: | X-RAY DIFFRACTION (3 Å) | Cite: | Crystal structure of human mre11: understanding tumorigenic mutations Structure, 19, 2011
|
|
5GGU
| Crystal structure of tremelimumab Fab | Descriptor: | heavy chain, light chain | Authors: | Heo, Y.S. | Deposit date: | 2016-06-16 | Release date: | 2016-11-09 | Last modified: | 2016-11-16 | Method: | X-RAY DIFFRACTION (2.292 Å) | Cite: | Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy Nat Commun, 7, 2016
|
|
5GGS
| PD-1 in complex with pembrolizumab Fab | Descriptor: | Programmed cell death protein 1, heavy chain, light chain | Authors: | Heo, Y.S. | Deposit date: | 2016-06-16 | Release date: | 2016-11-09 | Last modified: | 2016-11-16 | Method: | X-RAY DIFFRACTION (1.997 Å) | Cite: | Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy Nat Commun, 7, 2016
|
|
5GGV
| CTLA-4 in complex with tremelimumab Fab | Descriptor: | Cytotoxic T-lymphocyte protein 4, heavy chain, light chain | Authors: | Heo, Y.S. | Deposit date: | 2016-06-16 | Release date: | 2016-11-09 | Last modified: | 2016-11-16 | Method: | X-RAY DIFFRACTION (1.998 Å) | Cite: | Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy Nat Commun, 7, 2016
|
|
5GGT
| PD-L1 in complex with BMS-936559 Fab | Descriptor: | IGK@ protein, IgG H chain, Programmed cell death 1 ligand 1 | Authors: | Heo, Y.S. | Deposit date: | 2016-06-16 | Release date: | 2016-11-09 | Last modified: | 2024-03-20 | Method: | X-RAY DIFFRACTION (2.8 Å) | Cite: | Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy Nat Commun, 7, 2016
|
|
5GGR
| PD-1 in complex with nivolumab Fab | Descriptor: | Programmed cell death protein 1, heavy chain, light chain | Authors: | Heo, Y.S. | Deposit date: | 2016-06-16 | Release date: | 2016-11-09 | Last modified: | 2016-11-16 | Method: | X-RAY DIFFRACTION (3.3 Å) | Cite: | Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy Nat Commun, 7, 2016
|
|
5GGQ
| Crystal structure of Nivolumab Fab fragment | Descriptor: | nivolumab heavy chain, nivolumab light chain | Authors: | Heo, Y.S. | Deposit date: | 2016-06-16 | Release date: | 2016-11-09 | Last modified: | 2016-11-16 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy Nat Commun, 7, 2016
|
|